- Title
- Retraction Note: Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer
- Creators
- Yunhua Liu - The University of Texas MD Anderson Cancer CenterJiangsheng Xu - The Ohio State UniversityHyun Ho Choi - The University of Texas MD Anderson Cancer CenterCecil Han - The University of Texas MD Anderson Cancer CenterYuanzhang Fang - The University of Texas MD Anderson Cancer CenterYujing Li - The University of Texas MD Anderson Cancer CenterKevin Van der Jeught - The University of Texas MD Anderson Cancer CenterHanchen Xu - The University of Texas MD Anderson Cancer CenterLu Zhang - Indianapolis, IN 46202 USA Houston, TX 77030 USA 200032 Shanghai, ChinaMichael Frieden - Indiana University School of MedicineLifei Wang - Indiana University School of MedicineHaniyeh Eyvani - Indiana University School of MedicineYifan Sun - Indiana University School of MedicineGang Zhao - University of Science and Technology of ChinaYuntian Zhang - The Ohio State UniversitySheng Liu - Indiana University School of MedicineJun Wan - Indiana University School of MedicineCheng Huang - Shanghai University of Traditional Chinese MedicineGuang Ji - Longhua Hospital Shanghai University of Traditional Chinese MedicineXiongbin Lu - Indiana University HealthXiaoming He - University of Maryland, BaltimoreXinna Zhang - Indiana University Health
- Publication Details
- Nature communications, Vol.17(1), p.5628
- Publisher
- Nature Publishing Group; BERLIN
- Number of pages
- 1
- Academic Unit
- Miller School of Medicine; Microbiology and Immunology Research
- Language
- English
- Resource Type
- Journal article
- PMID
- 42373631
- Record Identifier
- 991033132180602976
Journal article
Retraction Note: Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer
Nature communications, Vol.17(1), p.5628
2026-06-29
PMID: 42373631
Metrics
1 Record Views